Youhe Pharmaceutical Technology

Youhe Biopharma is a clinical-stage biopharmaceutical company based in Suzhou, China, focused on the discovery and development of innovative small molecule drugs and protein degraders. The company leverages its proprietary PROTAC (Proteolysis-Targeting Chimera) platform and medicinal chemistry expertise to target high-value, difficult-to-drug pathways in oncology and immunology. Its lead program, YH-101, is a potent KRAS G12C inhibitor currently in clinical development for solid tumors. Additionally, the company is advancing a robust pipeline of protein degraders, including an EGFR-targeting PROTAC designed to overcome clinical resistance in lung cancer. Youhe Biopharma aims to provide transformative precision medicines for patients with unmet medical needs globally.